Check-Cap Ltd. (CHEK) 10-Year Financial Performance & Capital Metrics

CHEK • • Industrial / General

HealthcareDiagnostics & ResearchDigital Health & Point-of-Care DiagnosticsRapid Diagnostic Technologies

AboutCheck-Cap Ltd., a clinical stage medical diagnostics company, engages in the development of a capsule-based screening technology that utilizes ultra-low-dose X-rays to scan the inner lining of the colon for precancerous polyps, and other structural abnormalities in Israel. Its C-Scan system consists of C-Scan Cap, an X-ray scanning capsule for detection of suspected polyps; C-Scan Track, a disposable system attached to the patient's back through biocompatible adhesive skin patches; and C-Scan View software, a client/server-based application that enables procedure data download from the C-Scan Track, data analysis, and report generation. The company was incorporated in 2004 and is based in Isfiya, Israel.Show more

Revenue $0
EBITDA -$26M -35.2%
Net Income -$25M -43.2%
EPS (Diluted) -4.30 -43.3%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -226.19% -318.4%
ROIC -287.7% -427.4%
Debt/Equity -
Interest Coverage -2883.22 -94.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 91 (top 9%)

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Low quality earnings: Net income not backed by cash flow
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-46.56%

EPS CAGR

10Y-

5Y-

3Y-

TTM-46.26%

ROCE

10Y Avg-108.79%

5Y Avg-101.02%

3Y Avg-111.57%

Latest-233.22%

Peer Comparison

Rapid Diagnostic Technologies

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
CHEKCheck-Cap Ltd.	10.24M	1.75	-0.41			-226.19%
NDRAENDRA Life Sciences Inc.	5.21M	4.47	-0.44			-5.95%	0.23
INBSIntelligent Bio Solutions Inc.	17.54M	14.42	-7.21	-1.9%	-330.06%	-317.07%	0.10

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	173K	244K	0	0	0	0	0	0	0	0
Revenue Growth %	1.22%	0.41%	-1%	-	-	-	-	-	-	-
Cost of Goods Sold+	92K	130K	157K	148K	115K	148K	205K	405K	212K	161K
COGS % of Revenue	0.53%	0.53%	-	-	-	-	-	-	-	-
Gross Profit+	81K	114K	-157K	-148K	-115K	-148K	-205K	-405K	-212K	-161K
Gross Margin %	0.47%	0.47%	-	-	-	-	-	-	-	-
Gross Profit Growth %	1.1%	0.41%	-2.38%	0.06%	0.22%	-0.29%	-0.39%	-0.98%	0.48%	0.24%
Operating Expenses+	12.46M	9.06M	10M	11.06M	14.07M	13.93M	17.32M	20.03M	17.65M	25.95M
OpEx % of Revenue	72.04%	37.14%	-	-	-	-	-	-	-	-
Selling, General & Admin	6.63M	3.57M	3.16M	3.44M	3.6M	3.92M	4.97M	5.76M	9.55M	9.46M
SG&A % of Revenue	38.3%	14.64%	-	-	-	-	-	-	-	-
Research & Development	5.84M	5.49M	6.84M	7.62M	10.47M	10.01M	12.35M	14.27M	8.29M	0
R&D % of Revenue	33.74%	22.5%	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	-195K	16.49M
Operating Income+	-12.46M	-9.06M	-10M	-11.06M	-14.07M	-13.93M	-17.32M	-20.03M	-19.29M	-25.95M
Operating Margin %	-72.04%	-37.14%	-	-	-	-	-	-	-	-
Operating Income Growth %	-1.59%	0.27%	-0.1%	-0.11%	-0.27%	0.01%	-0.24%	-0.16%	0.04%	-0.35%
EBITDA+	-12.37M	-8.93M	-9.84M	-10.91M	-13.95M	-13.78M	-17.12M	-19.63M	-19.07M	-25.79M
EBITDA Margin %	-71.51%	-36.61%	-	-	-	-	-	-	-	-
EBITDA Growth %	-1.61%	0.28%	-0.1%	-0.11%	-0.28%	0.01%	-0.24%	-0.15%	0.03%	-0.35%
D&A (Non-Cash Add-back)	92K	130K	157K	148K	115K	148K	205K	405K	212K	161K
EBIT	-12.32M	-9.06M	-10M	-10.58M	-14.07M	-13.83M	-17.19M	-19.1M	-17.86M	-9.46M
Net Interest Income+	14K	132K	59K	236K	237K	57K	106K	914K	1.76M	800K
Interest Income	61K	139K	66K	243K	245K	69K	119K	926K	1.77M	809K
Interest Expense	47K	7K	7K	7K	8K	12K	13K	12K	13K	9K
Other Income/Expense	173K	244K	236K	473K	233K	86K	119K	926K	293K	800K
Pretax Income+	-12.29M	-8.82M	-9.77M	-10.59M	-13.84M	-13.85M	-17.2M	-19.11M	-17.57M	-25.15M
Pretax Margin %	-71.04%	-36.14%	-	-	-	-	-	-	-	-
Income Tax+	0	8K	6K	-1K	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-12.29M	-8.83M	-9.77M	-10.59M	-13.84M	-13.85M	-17.2M	-19.11M	-17.57M	-25.15M
Net Margin %	-71.04%	-36.17%	-	-	-	-	-	-	-	-
Net Income Growth %	-2.02%	0.28%	-0.11%	-0.08%	-0.31%	-0%	-0.24%	-0.11%	0.08%	-0.43%
Net Income (Continuing)	-12.29M	-8.83M	-9.77M	-10.59M	-13.84M	-13.85M	-17.2M	-19.11M	-17.57M	-25.15M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-247.49	-146.10	-134.31	-52.19	-34.05	-9.12	-4.13	-3.37	-3.00	-4.30
EPS Growth %	-2.01%	0.41%	0.08%	0.61%	0.35%	0.73%	0.55%	0.18%	0.11%	-0.43%
EPS (Basic)	-247.49	-146.10	-134.31	-52.19	-34.05	-9.12	-4.13	-3.37	-3.00	-4.30
Diluted Shares Outstanding	49.66K	60.41K	72.75K	202.9K	399.3K	1.52M	4.14M	5.67M	5.85M	5.85M
Basic Shares Outstanding	49.66K	60.41K	72.75K	202.9K	399.3K	1.52M	4.14M	5.67M	5.85M	5.85M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	14.93M	11.88M	7.4M	14.98M	8.44M	18.42M	52.75M	42.63M	24.86M	265K
Cash & Short-Term Investments	14.2M	11.64M	7M	14.21M	7.68M	17.78M	51.56M	41.7M	24.76M	265K
Cash Only	9.39M	11.64M	7M	8.57M	7.68M	7.7M	26.46M	4.09M	8.84M	0
Short-Term Investments	4.81M	0	0	5.64M	0	10.08M	25.1M	37.61M	15.91M	265K
Accounts Receivable	0	0	0	0	0	142K	206K	88K	44K	0
Days Sales Outstanding	-	-	-	-	-	-	-	-	-	-
Inventory	-4.91M	48K	-89K	0	193K	208K	144K	264K	0	0
Days Inventory Outstanding	-	134.77	-	-	612.57	512.97	256.39	237.93	-	-
Other Current Assets	474K	0	90K	529K	346K	150K	356K	311K	21K	0
Total Non-Current Assets+	369K	414K	503K	452K	994K	1.22M	2.91M	2.81M	161K	112K
Property, Plant & Equipment	369K	414K	503K	452K	994K	1.22M	2.91M	2.81M	161K	112K
Fixed Asset Turnover	0.47x	0.59x	-	-	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	0	0	0	0	0	0	0	0
Total Assets+	15.3M	12.29M	7.91M	15.44M	9.43M	19.64M	55.66M	45.44M	25.02M	377K
Asset Turnover	0.01x	0.02x	-	-	-	-	-	-	-	-
Asset Growth %	0.97%	-0.2%	-0.36%	0.95%	-0.39%	1.08%	1.83%	-0.18%	-0.45%	-0.98%
Total Current Liabilities+	2.07M	1.37M	1.56M	2.22M	2.8M	2.98M	4.04M	3.41M	1.33M	1.81M
Accounts Payable	577K	393K	608K	1.11M	989K	862K	1.05M	952K	141K	492K
Days Payables Outstanding	2.29K	1.1K	1.41K	2.74K	3.14K	2.13K	1.87K	857.98	242.76	1.12K
Short-Term Debt	0	0	0	0	222K	264K	350K	337K	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	258K	246K	352K	249K	490K	81K	330K	521K	783K	142K
Current Ratio	7.20x	8.69x	4.74x	6.75x	3.01x	6.18x	13.05x	12.51x	18.69x	0.15x
Quick Ratio	9.57x	8.66x	4.80x	6.75x	2.94x	6.11x	13.02x	12.43x	18.69x	0.15x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	577K	521K	439K	185K	393K	279K	927K	721K	0	16K
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	211K	125K	795K	627K	0	16K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	577K	521K	439K	185K	182K	154K	132K	94K	0	0
Total Liabilities	2.65M	1.89M	2M	2.41M	3.19M	3.26M	4.97M	4.13M	1.33M	1.83M
Total Debt+	0	0	0	0	433K	389K	1.15M	964K	0	136K
Net Debt	-9.39M	-11.64M	-7M	-8.57M	-7.25M	-7.31M	-25.31M	-3.13M	-8.84M	136K
Debt / Equity	-	-	-	-	0.07x	0.02x	0.02x	0.02x	-	-
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-265.17x	-1294.57x	-1428.71x	-1580.43x	-1758.63x	-1161.00x	-1332.38x	-1669.50x	-1483.62x	-2883.22x
Total Equity+	12.65M	10.41M	5.91M	13.03M	6.23M	16.38M	50.69M	41.31M	23.69M	-1.45M
Equity Growth %	4.68%	-0.18%	-0.43%	1.21%	-0.52%	1.63%	2.1%	-0.19%	-0.43%	-1.06%
Book Value per Share	254.70	172.27	81.17	64.22	15.61	10.79	12.24	7.28	4.05	-0.25
Total Shareholders' Equity	12.65M	10.41M	5.91M	13.03M	6.23M	16.38M	50.69M	41.31M	23.69M	-1.45M
Common Stock	599K	771K	974K	3.46M	5.41M	31.65M	68.79M	83.66M	83.75M	83.75M
Retained Earnings	-34.12M	-42.94M	-52.71M	-63.3M	-77.14M	-90.98M	-108.19M	-127.29M	-144.86M	-170.01M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-505K	-462K	-619K	-13K	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-8.63M	-7.92M	-9.15M	-10.03M	-12.84M	-13.11M	-16.26M	-18.71M	-16.95M	-8K
Operating CF Margin %	-49.87%	-32.47%	-	-	-	-	-	-	-	-
Operating CF Growth %	-0.9%	0.08%	-0.15%	-0.1%	-0.28%	-0.02%	-0.24%	-0.15%	0.09%	1%
Net Income	-12.29M	-8.83M	-9.77M	-10.59M	-13.84M	-13.85M	-17.2M	-19.11M	-17.57M	-25.15M
Depreciation & Amortization	92K	130K	157K	147K	115K	148K	205K	404K	212K	161K
Stock-Based Compensation	3.72M	1.21M	726K	-65K	516K	408K	491K	879K	-57K	12K
Deferred Taxes	0	0	0	0	0	0	-539K	0	0	0
Other Non-Cash Items	-185K	-56K	-165K	67K	40K	7K	539K	-624K	1.73M	24.97M
Working Capital Changes	31K	-380K	-97K	406K	322K	170K	242K	-258K	-1.27M	-12
Change in Receivables	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	334K	-252K	275K	416K	503K	-317K	362K	207K	-851K	497K
Cash from Investing+	-5.07M	4.69M	-231K	-5.72M	5.45M	-10.45M	-16.01M	-12.51M	21.36M	-840
Capital Expenditures	-270K	-166K	-231K	-94K	-167K	-379K	-1.01M	-486K	-83K	0
CapEx % of Revenue	1.56%	0.68%	-	-	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-4.8M	4.86M	0	-5.63M	0	0	0	0	0	-840
Cash from Financing+	22.01M	5.42M	4.58M	17.76M	6.51M	23.58M	51.02M	8.85M	0	0
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	45K	117K	196K	0	0	0	19.22M	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-8.9M	-8.09M	-9.38M	-10.13M	-13.01M	-13.49M	-17.27M	-19.19M	-17.04M	-8K
FCF Margin %	-51.43%	-33.15%	-	-	-	-	-	-	-	-
FCF Growth %	-0.94%	0.09%	-0.16%	-0.08%	-0.28%	-0.04%	-0.28%	-0.11%	0.11%	1%
FCF per Share	-179.19	-133.90	-128.95	-49.92	-32.58	-8.89	-4.17	-3.38	-2.91	-0.00
FCF Conversion (FCF/Net Income)	0.70x	0.90x	0.94x	0.95x	0.93x	0.95x	0.95x	0.98x	0.97x	0.00x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	8K	3K	5K	15K	5K	33K	5K	25K	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-165.24%	-76.56%	-119.8%	-111.85%	-143.65%	-122.47%	-51.3%	-41.54%	-54.06%	-226.19%
Return on Invested Capital (ROIC)	-424.1%	-671.59%	-	-493%	-613.47%	-259.73%	-75.43%	-47.28%	-54.56%	-287.7%
Gross Margin	46.82%	46.72%	-	-	-	-	-	-	-	-
Net Margin	-7104.05%	-3617.21%	-	-	-	-	-	-	-	-
Debt / Equity	-	-	-	-	0.07x	0.02x	0.02x	0.02x	-	-
Interest Coverage	-265.17x	-1294.57x	-1428.71x	-1580.43x	-1758.63x	-1161.00x	-1332.38x	-1669.50x	-1483.62x	-2883.22x
FCF Conversion	0.70x	0.90x	0.94x	0.95x	0.93x	0.95x	0.95x	0.98x	0.97x	0.00x
Revenue Growth	121.95%	41.04%	-100%	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Check-Cap Ltd. (CHEK) grew revenue by 0.0% over the past year. Growth has been modest.

Check-Cap Ltd. (CHEK) reported a net loss of $25.1M for fiscal year 2024.

Dividend & Returns

Check-Cap Ltd. (CHEK) has a return on equity (ROE) of -226.2%. Negative ROE indicates the company is unprofitable.

Check-Cap Ltd. (CHEK) had negative free cash flow of $0.0M in fiscal year 2024, likely due to heavy capital investments.

US Stock Screener

...

Check-Cap Ltd. (CHEK) 10-Year Financial Performance & Capital Metrics

CHEK • • Industrial / General

HealthcareDiagnostics & ResearchDigital Health & Point-of-Care DiagnosticsRapid Diagnostic Technologies

Revenue $0
EBITDA -$26M -35.2%
Net Income -$25M -43.2%
EPS (Diluted) -4.30 -43.3%
Gross Margin -
EBITDA Margin -
Operating Margin -
Net Margin -
ROE -226.19% -318.4%
ROIC -287.7% -427.4%
Debt/Equity -
Interest Coverage -2883.22 -94.3%

Technical Analysis

Key Insights

Based on financial data analysis

✓Strengths

✓Momentum leader: RS Rating 91 (top 9%)

✗Weaknesses

✗Weak Piotroski F-Score: 2/9
✗Low quality earnings: Net income not backed by cash flow
✗Trading more than 30% below 52-week high
✗Low asset turnover indicates capital-intensive operations

Price & Volume

Loading chart...

Growth Metrics

Revenue CAGR

10Y-

5Y-

3Y-

TTM-

Profit (Net Income) CAGR

10Y-

5Y-

3Y-

TTM-46.56%

EPS CAGR

10Y-

5Y-

3Y-

TTM-46.26%

ROCE

10Y Avg-108.79%

5Y Avg-101.02%

3Y Avg-111.57%

Latest-233.22%

Peer Comparison

Rapid Diagnostic Technologies

Name	Market Cap	Current Price	P/E Ratio	Revenue Growth 1Y	Net Margin	ROE	Debt/Equity
CHEKCheck-Cap Ltd.	10.24M	1.75	-0.41			-226.19%
NDRAENDRA Life Sciences Inc.	5.21M	4.47	-0.44			-5.95%	0.23
INBSIntelligent Bio Solutions Inc.	17.54M	14.42	-7.21	-1.9%	-330.06%	-317.07%	0.10

Profit & Loss

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Sales/Revenue+	173K	244K	0	0	0	0	0	0	0	0
Revenue Growth %	1.22%	0.41%	-1%	-	-	-	-	-	-	-
Cost of Goods Sold+	92K	130K	157K	148K	115K	148K	205K	405K	212K	161K
COGS % of Revenue	0.53%	0.53%	-	-	-	-	-	-	-	-
Gross Profit+	81K	114K	-157K	-148K	-115K	-148K	-205K	-405K	-212K	-161K
Gross Margin %	0.47%	0.47%	-	-	-	-	-	-	-	-
Gross Profit Growth %	1.1%	0.41%	-2.38%	0.06%	0.22%	-0.29%	-0.39%	-0.98%	0.48%	0.24%
Operating Expenses+	12.46M	9.06M	10M	11.06M	14.07M	13.93M	17.32M	20.03M	17.65M	25.95M
OpEx % of Revenue	72.04%	37.14%	-	-	-	-	-	-	-	-
Selling, General & Admin	6.63M	3.57M	3.16M	3.44M	3.6M	3.92M	4.97M	5.76M	9.55M	9.46M
SG&A % of Revenue	38.3%	14.64%	-	-	-	-	-	-	-	-
Research & Development	5.84M	5.49M	6.84M	7.62M	10.47M	10.01M	12.35M	14.27M	8.29M	0
R&D % of Revenue	33.74%	22.5%	-	-	-	-	-	-	-	-
Other Operating Expenses	0	0	0	0	0	0	0	0	-195K	16.49M
Operating Income+	-12.46M	-9.06M	-10M	-11.06M	-14.07M	-13.93M	-17.32M	-20.03M	-19.29M	-25.95M
Operating Margin %	-72.04%	-37.14%	-	-	-	-	-	-	-	-
Operating Income Growth %	-1.59%	0.27%	-0.1%	-0.11%	-0.27%	0.01%	-0.24%	-0.16%	0.04%	-0.35%
EBITDA+	-12.37M	-8.93M	-9.84M	-10.91M	-13.95M	-13.78M	-17.12M	-19.63M	-19.07M	-25.79M
EBITDA Margin %	-71.51%	-36.61%	-	-	-	-	-	-	-	-
EBITDA Growth %	-1.61%	0.28%	-0.1%	-0.11%	-0.28%	0.01%	-0.24%	-0.15%	0.03%	-0.35%
D&A (Non-Cash Add-back)	92K	130K	157K	148K	115K	148K	205K	405K	212K	161K
EBIT	-12.32M	-9.06M	-10M	-10.58M	-14.07M	-13.83M	-17.19M	-19.1M	-17.86M	-9.46M
Net Interest Income+	14K	132K	59K	236K	237K	57K	106K	914K	1.76M	800K
Interest Income	61K	139K	66K	243K	245K	69K	119K	926K	1.77M	809K
Interest Expense	47K	7K	7K	7K	8K	12K	13K	12K	13K	9K
Other Income/Expense	173K	244K	236K	473K	233K	86K	119K	926K	293K	800K
Pretax Income+	-12.29M	-8.82M	-9.77M	-10.59M	-13.84M	-13.85M	-17.2M	-19.11M	-17.57M	-25.15M
Pretax Margin %	-71.04%	-36.14%	-	-	-	-	-	-	-	-
Income Tax+	0	8K	6K	-1K	0	0	0	0	0	0
Effective Tax Rate %	1%	1%	1%	1%	1%	1%	1%	1%	1%	1%
Net Income+	-12.29M	-8.83M	-9.77M	-10.59M	-13.84M	-13.85M	-17.2M	-19.11M	-17.57M	-25.15M
Net Margin %	-71.04%	-36.17%	-	-	-	-	-	-	-	-
Net Income Growth %	-2.02%	0.28%	-0.11%	-0.08%	-0.31%	-0%	-0.24%	-0.11%	0.08%	-0.43%
Net Income (Continuing)	-12.29M	-8.83M	-9.77M	-10.59M	-13.84M	-13.85M	-17.2M	-19.11M	-17.57M	-25.15M
Discontinued Operations	0	0	0	0	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0
EPS (Diluted)+	-247.49	-146.10	-134.31	-52.19	-34.05	-9.12	-4.13	-3.37	-3.00	-4.30
EPS Growth %	-2.01%	0.41%	0.08%	0.61%	0.35%	0.73%	0.55%	0.18%	0.11%	-0.43%
EPS (Basic)	-247.49	-146.10	-134.31	-52.19	-34.05	-9.12	-4.13	-3.37	-3.00	-4.30
Diluted Shares Outstanding	49.66K	60.41K	72.75K	202.9K	399.3K	1.52M	4.14M	5.67M	5.85M	5.85M
Basic Shares Outstanding	49.66K	60.41K	72.75K	202.9K	399.3K	1.52M	4.14M	5.67M	5.85M	5.85M
Dividend Payout Ratio	-	-	-	-	-	-	-	-	-	-

Balance Sheet

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Total Current Assets+	14.93M	11.88M	7.4M	14.98M	8.44M	18.42M	52.75M	42.63M	24.86M	265K
Cash & Short-Term Investments	14.2M	11.64M	7M	14.21M	7.68M	17.78M	51.56M	41.7M	24.76M	265K
Cash Only	9.39M	11.64M	7M	8.57M	7.68M	7.7M	26.46M	4.09M	8.84M	0
Short-Term Investments	4.81M	0	0	5.64M	0	10.08M	25.1M	37.61M	15.91M	265K
Accounts Receivable	0	0	0	0	0	142K	206K	88K	44K	0
Days Sales Outstanding	-	-	-	-	-	-	-	-	-	-
Inventory	-4.91M	48K	-89K	0	193K	208K	144K	264K	0	0
Days Inventory Outstanding	-	134.77	-	-	612.57	512.97	256.39	237.93	-	-
Other Current Assets	474K	0	90K	529K	346K	150K	356K	311K	21K	0
Total Non-Current Assets+	369K	414K	503K	452K	994K	1.22M	2.91M	2.81M	161K	112K
Property, Plant & Equipment	369K	414K	503K	452K	994K	1.22M	2.91M	2.81M	161K	112K
Fixed Asset Turnover	0.47x	0.59x	-	-	-	-	-	-	-	-
Goodwill	0	0	0	0	0	0	0	0	0	0
Intangible Assets	0	0	0	0	0	0	0	0	0	0
Long-Term Investments	0	0	0	0	0	0	0	0	0	0
Other Non-Current Assets	0	0	0	0	0	0	0	0	0	0
Total Assets+	15.3M	12.29M	7.91M	15.44M	9.43M	19.64M	55.66M	45.44M	25.02M	377K
Asset Turnover	0.01x	0.02x	-	-	-	-	-	-	-	-
Asset Growth %	0.97%	-0.2%	-0.36%	0.95%	-0.39%	1.08%	1.83%	-0.18%	-0.45%	-0.98%
Total Current Liabilities+	2.07M	1.37M	1.56M	2.22M	2.8M	2.98M	4.04M	3.41M	1.33M	1.81M
Accounts Payable	577K	393K	608K	1.11M	989K	862K	1.05M	952K	141K	492K
Days Payables Outstanding	2.29K	1.1K	1.41K	2.74K	3.14K	2.13K	1.87K	857.98	242.76	1.12K
Short-Term Debt	0	0	0	0	222K	264K	350K	337K	0	0
Deferred Revenue (Current)	0	0	0	0	0	0	0	0	0	0
Other Current Liabilities	258K	246K	352K	249K	490K	81K	330K	521K	783K	142K
Current Ratio	7.20x	8.69x	4.74x	6.75x	3.01x	6.18x	13.05x	12.51x	18.69x	0.15x
Quick Ratio	9.57x	8.66x	4.80x	6.75x	2.94x	6.11x	13.02x	12.43x	18.69x	0.15x
Cash Conversion Cycle	-	-	-	-	-	-	-	-	-	-
Total Non-Current Liabilities+	577K	521K	439K	185K	393K	279K	927K	721K	0	16K
Long-Term Debt	0	0	0	0	0	0	0	0	0	0
Capital Lease Obligations	0	0	0	0	211K	125K	795K	627K	0	16K
Deferred Tax Liabilities	0	0	0	0	0	0	0	0	0	0
Other Non-Current Liabilities	577K	521K	439K	185K	182K	154K	132K	94K	0	0
Total Liabilities	2.65M	1.89M	2M	2.41M	3.19M	3.26M	4.97M	4.13M	1.33M	1.83M
Total Debt+	0	0	0	0	433K	389K	1.15M	964K	0	136K
Net Debt	-9.39M	-11.64M	-7M	-8.57M	-7.25M	-7.31M	-25.31M	-3.13M	-8.84M	136K
Debt / Equity	-	-	-	-	0.07x	0.02x	0.02x	0.02x	-	-
Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Net Debt / EBITDA	-	-	-	-	-	-	-	-	-	-
Interest Coverage	-265.17x	-1294.57x	-1428.71x	-1580.43x	-1758.63x	-1161.00x	-1332.38x	-1669.50x	-1483.62x	-2883.22x
Total Equity+	12.65M	10.41M	5.91M	13.03M	6.23M	16.38M	50.69M	41.31M	23.69M	-1.45M
Equity Growth %	4.68%	-0.18%	-0.43%	1.21%	-0.52%	1.63%	2.1%	-0.19%	-0.43%	-1.06%
Book Value per Share	254.70	172.27	81.17	64.22	15.61	10.79	12.24	7.28	4.05	-0.25
Total Shareholders' Equity	12.65M	10.41M	5.91M	13.03M	6.23M	16.38M	50.69M	41.31M	23.69M	-1.45M
Common Stock	599K	771K	974K	3.46M	5.41M	31.65M	68.79M	83.66M	83.75M	83.75M
Retained Earnings	-34.12M	-42.94M	-52.71M	-63.3M	-77.14M	-90.98M	-108.19M	-127.29M	-144.86M	-170.01M
Treasury Stock	0	0	0	0	0	0	0	0	0	0
Accumulated OCI	-505K	-462K	-619K	-13K	0	0	0	0	0	0
Minority Interest	0	0	0	0	0	0	0	0	0	0

Cash Flow

	Dec 2015	Dec 2016	Dec 2017	Dec 2018	Dec 2019	Dec 2020	Dec 2021	Dec 2022	Dec 2023	Dec 2024
Cash from Operations+	-8.63M	-7.92M	-9.15M	-10.03M	-12.84M	-13.11M	-16.26M	-18.71M	-16.95M	-8K
Operating CF Margin %	-49.87%	-32.47%	-	-	-	-	-	-	-	-
Operating CF Growth %	-0.9%	0.08%	-0.15%	-0.1%	-0.28%	-0.02%	-0.24%	-0.15%	0.09%	1%
Net Income	-12.29M	-8.83M	-9.77M	-10.59M	-13.84M	-13.85M	-17.2M	-19.11M	-17.57M	-25.15M
Depreciation & Amortization	92K	130K	157K	147K	115K	148K	205K	404K	212K	161K
Stock-Based Compensation	3.72M	1.21M	726K	-65K	516K	408K	491K	879K	-57K	12K
Deferred Taxes	0	0	0	0	0	0	-539K	0	0	0
Other Non-Cash Items	-185K	-56K	-165K	67K	40K	7K	539K	-624K	1.73M	24.97M
Working Capital Changes	31K	-380K	-97K	406K	322K	170K	242K	-258K	-1.27M	-12
Change in Receivables	0	0	0	0	0	0	0	0	0	0
Change in Inventory	0	0	0	0	0	0	0	0	0	0
Change in Payables	334K	-252K	275K	416K	503K	-317K	362K	207K	-851K	497K
Cash from Investing+	-5.07M	4.69M	-231K	-5.72M	5.45M	-10.45M	-16.01M	-12.51M	21.36M	-840
Capital Expenditures	-270K	-166K	-231K	-94K	-167K	-379K	-1.01M	-486K	-83K	0
CapEx % of Revenue	1.56%	0.68%	-	-	-	-	-	-	-	-
Acquisitions	-	-	-	-	-	-	-	-	-	-
Investments	-	-	-	-	-	-	-	-	-	-
Other Investing	-4.8M	4.86M	0	-5.63M	0	0	0	0	0	-840
Cash from Financing+	22.01M	5.42M	4.58M	17.76M	6.51M	23.58M	51.02M	8.85M	0	0
Debt Issued (Net)	-	-	-	-	-	-	-	-	-	-
Equity Issued (Net)	-	-	-	-	-	-	-	-	-	-
Dividends Paid	0	0	0	0	0	0	0	0	0	0
Share Repurchases	-	-	-	-	-	-	-	-	-	-
Other Financing	45K	117K	196K	0	0	0	19.22M	0	0	0
Net Change in Cash	-	-	-	-	-	-	-	-	-	-
Free Cash Flow+	-8.9M	-8.09M	-9.38M	-10.13M	-13.01M	-13.49M	-17.27M	-19.19M	-17.04M	-8K
FCF Margin %	-51.43%	-33.15%	-	-	-	-	-	-	-	-
FCF Growth %	-0.94%	0.09%	-0.16%	-0.08%	-0.28%	-0.04%	-0.28%	-0.11%	0.11%	1%
FCF per Share	-179.19	-133.90	-128.95	-49.92	-32.58	-8.89	-4.17	-3.38	-2.91	-0.00
FCF Conversion (FCF/Net Income)	0.70x	0.90x	0.94x	0.95x	0.93x	0.95x	0.95x	0.98x	0.97x	0.00x
Interest Paid	0	0	0	0	0	0	0	0	0	0
Taxes Paid	0	8K	3K	5K	15K	5K	33K	5K	25K	0

Key Ratios

Metric	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024
Return on Equity (ROE)	-165.24%	-76.56%	-119.8%	-111.85%	-143.65%	-122.47%	-51.3%	-41.54%	-54.06%	-226.19%
Return on Invested Capital (ROIC)	-424.1%	-671.59%	-	-493%	-613.47%	-259.73%	-75.43%	-47.28%	-54.56%	-287.7%
Gross Margin	46.82%	46.72%	-	-	-	-	-	-	-	-
Net Margin	-7104.05%	-3617.21%	-	-	-	-	-	-	-	-
Debt / Equity	-	-	-	-	0.07x	0.02x	0.02x	0.02x	-	-
Interest Coverage	-265.17x	-1294.57x	-1428.71x	-1580.43x	-1758.63x	-1161.00x	-1332.38x	-1669.50x	-1483.62x	-2883.22x
FCF Conversion	0.70x	0.90x	0.94x	0.95x	0.93x	0.95x	0.95x	0.98x	0.97x	0.00x
Revenue Growth	121.95%	41.04%	-100%	-	-	-	-	-	-	-

Frequently Asked Questions

Growth & Financials

Check-Cap Ltd. (CHEK) grew revenue by 0.0% over the past year. Growth has been modest.

Check-Cap Ltd. (CHEK) reported a net loss of $25.1M for fiscal year 2024.

Dividend & Returns

Check-Cap Ltd. (CHEK) has a return on equity (ROE) of -226.2%. Negative ROE indicates the company is unprofitable.

Check-Cap Ltd. (CHEK) had negative free cash flow of $0.0M in fiscal year 2024, likely due to heavy capital investments.